3-aminobenzamide has been researched along with acetyl-aspartyl-glutamyl-valyl-aspartal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chung, EH; Egashira, N; Fujiwara, M; Hatip-Al-Khatib, I; Iwasaki, K; Mishima, K | 1 |
2 other study(ies) available for 3-aminobenzamide and acetyl-aspartyl-glutamyl-valyl-aspartal
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of poly (ADP-ribose) polymerase and caspase-3, but not caspase-1, prevents apoptosis and improves spatial memory of rats with twice-repeated cerebral ischemia.
Topics: Animals; Apoptosis; Benzamides; Brain Ischemia; Caspase 1; Caspase 3; Caspase Inhibitors; Dose-Response Relationship, Drug; In Situ Nick-End Labeling; Male; Memory Disorders; Oligopeptides; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Wistar | 2004 |